Ebola is a strong virus that first surfaced about 40 years ago. When it first appeared, the disease hit a small village in central africa, costing the lives of 280 of the people who contracted it. Thankfully the virus was contained to that village at the time and wasn’t much of a threat in the recent decades since then. However, last year the virus made headlines as it rampaged through West Africa infecting more than seven thousand people and killing more than three thousand four hundred of the infected. This massive loss prompted the World Health Organization to declare a red alert and urge all scientists to focus on defeating this deadly disease as soon as possible.
- Ebola causes a hemorrhagic fever in those that it infects and causes secretion of highly contagious bodily fluids and vomiting of blood. Anyone who then comes into contact with any of these bodily fluids, ranging from sweat to mucus and sperm, will immediately contract the disease. This easy contagion made the disease especially hard to contain particularly in infrastructure-poor countries like those in West Africa.
- However after months of hard work on finding a vaccine, the WHO finally arrived at a positive outcome concerning this disease. In the last few months of 2016, the organisation tested a new vaccine in Guinea where nearly half of all Ebola cases were located. The results of the trial came as a much needed relief to poor African nations in particular and the world in general.
- In the almost 6000 people that the vaccine was given to, none have contracted the disease in this highly infected country, proving that the vaccine, called rVSV-ZEBOV, provided 100 % protection from Ebola to those to whom it was administered.
This originally Norwegian vaccine comes at the right time according to the study author making sure that the next time there’s an Ebola outbreak, humanity will not be defenseless.